Navigation Links
Study Finds Nearly One-Third of All Inexpensive Earrings Examined Tested Positive for Nickel
Date:5/12/2008

or platinum available from fine jewelry stores. A total of 277 earrings were purchased from four different categories of vendors -- a downtown market with licensed local artists producing custom-made jewelry; jewelry stores in China Town targeting mainly tourists; national and international clothing and accessory chain stores targeting mainly girls and women under age 40; and similar stores targeting mainly women over age 40.

All earrings purchased were examined with the dimethylglyoxime (DMG) test -- a routine spot test using solutions to detect the presence of nickel and other alloys. Of the 277 earrings that were tested, 85 (or 30.7 percent) demonstrated at least one spot that tested DMG-positive for nickel. Dr. Maibach noted that the highest proportion of DMG-positive earrings was purchased from local artists, with 69 percent of these earrings testing positive for nickel. A large portion (42.9 percent) of earrings purchased from stores in China Town also tested positive for nickel.

When the number of DMG-positive earrings was examined from accessory and clothing stores targeting younger women under age 40 and those stores targeting women over age 40, Dr. Maibach found a large discrepancy. Specifically, 24.1 percent of the earrings purchased at the stores targeting younger women tested positive for nickel; whereas only 1.7 percent of earrings from stores targeting women over 40 tested DMG positive.

"Except for one store targeting girls and young women where a significant number of DMG-positive earrings were found, the proportion of earrings that tested positive for nickel was generally higher among individual China Town stores and local artists than in individual national and international chain stores," said Dr. Maibach. "We also found no correlation between the country where the earrings were manufactured and the frequency of DMG-positive reactions or whether the price of the inexpensive earrings correlated with testing positive for nickel
'/>"/>

SOURCE American Academy of Dermatology
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Safe Options for Cardiac Lead Removal: Study Published in Heart Rhythm Journal
2. New Study Shows Lowering Co-payments Can Lead to Lower Total Healthcare Costs, Improved Overall Health
3. Study finds link between birth order and asthma symptoms
4. Study Offers Clues to Link Between Arrhythmia, Sudden Death
5. Study affirms effectiveness of medication for juvenile rheumatoid arthritis
6. Study identifies molecular response of cartilage to injury
7. Skin flaps deliver cancer-fighting therapy, ASPS study reveals
8. Pilot Study to Assess Safety and Efficacy of Medidur(TM) FA in AMD Patients Treated With Lucentis(R)
9. MIT study suggests caution on new anti-obesity drug in kids
10. Preliminary Results from Phase 2 Genzyme Study Highlight Potential of Novel Oral Compound for Gaucher Disease
11. Study in mice suggests molecules in plants have beneficial effect on Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 2Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 3Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 4Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 5Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 6Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 2Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 3ATS Medical Announces FDA Approval for a Landmark Clinical Investigation of the ATS 3f Aortic Bioprosthesis 4905 1ATS Medical Announces FDA Approval for a Landmark Clinical Investigation of the ATS 3f Aortic Bioprosthesis 4905 2ATS Medical Announces FDA Approval for a Landmark Clinical Investigation of the ATS 3f Aortic Bioprosthesis 4905 3Provocative New Fiction Makes for a Fascinating Fast Paced Read 13713 1Provocative New Fiction Makes for a Fascinating Fast Paced Read 13713 2LiveProcess Implements Emergency Management Platform with 51 Florida Hospitals 55482 1LiveProcess Implements Emergency Management Platform with 51 Florida Hospitals 55482 2